S U P P L E M E N T T O C O N S U L TA N T

September 79, 2012

Ballys Hotel & Casino Las Vegas, Nevada

Hypertension DyslipiDemia Diabetes obesity

Attendee Brochure
NCQAs Facilitating PCMH Recognition seminar, scheduled for Sept. 1011, will also be at Ballys!
See page 5 for details.
Partnering organizations:
For a list of organizations partnering with our meeting, please visit www.primarycarecardiometabolic.com

September 79, 2012

Ballys Hotel & Casino Las Vegas, Nevada

tABle oF CoNteNtS
2 3 4 5 Introduction Welcome Letter Accreditation Faculty 6 12 14 15 Program Schedule at a Glance Hotel & Travel Information Registration Form
MARKetiNG ANd MANAGeMeNt CoMPANy
, LLC
TM

ardiometabolic syndrome a constellation of factors including hypertension, diabetes, high cholesterol and obesity that increase the risk of cardiovascular disease is a nationwide epidemic, affecting 1 in 3 adults in the United States.

How PRevAleNt iS CARdioMetABoliC SyNdRoMe? Some sobering facts that have the potential to affect every patient in our primary care practices: HyPeRteNSioN. Approximately 1 in 3 adults have been diagnosed with hypertension, accounting for 46.3 million ambulatory visits each year. diABeteS. Diabetes affects nearly 8.3% of the U.S. population an estimated 25.8 million individuals and an additional 79 million people are considered to have prediabetes. HiGH CHoleSteRol. 16.3% of the adult population has high cholesterol, and individuals with high total cholesterol have approximately twice the risk of heart disease as people with optimal levels. oBeSity. 33.8% of the U.S. population is obese and 34% of individuals in the United States are overweight, putting them at risk for heart disease, stroke, type 2 diabetes and certain types of cancer. You can prevent your patients from becoming part of these statistics! Attend the Cardiometabolic Risk Summit to learn the latest strategies for reducing cardiometabolic risk in the primary care setting.

CMe ACCReditoR

North American Center for Continuing Medical education, llC 300 Rike Drive, Suite A Millstone Township, NJ 08535 Phone: 609-371-1137 Fax: 609-371-2733 www.naccme.com

HMP CoMMUNiCAtioNS, llC 83 General Warren Blvd. Suite 100 Malvern, PA 19355 Toll Free: 800-237-7285 Fax: 610-560-0502 www.hmpcommunications.com

Partnering organizations:

For a list of organizations partnering with our meeting, please visit www.primarycarecardiometabolic.com
Like Primary Care Cardiometabolic Risk Summit Follow @Consultant360

wHo SHoUld AtteNd This conference is intended for primary care physicians, internists, general practitioners, nurses, nurse practitioners, physician assistants, certified diabetes educators and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic syndrome.

Primary Care Cardiometabolic Risk Summit

Register online at www.primarycarecardiometabolic.com

dear Colleague, On behalf of Consultant, I am pleased to present the Primary Care Cardiometabolic Risk Summit, a unique educational experience dedicated to providing primary care practitioners with the knowledge and skills to combat a growing epidemic. As more and more of our patients develop the assortment of conditions known as cardiometabolic syndrome, primary care practitioners are faced with the challenge of treating this highly prevalent set of risk factors. Yet, many of us on the front lines of managing these risk factors are not adequately equipped with the latest information and available tools needed to ensure the best treatment possible. As the only national, multiday conference specifically designed for reducing cardiometabolic risk in the primary care setting, the Cardiometabolic Risk Summit to be held September 79, 2012 in Las Vegas, Nevada will convene primary care physicians, nurse practitioners, nurses, certified diabetes educators and physician assistants from across the country. The CMe/Ce agenda will include more than 20 educational lectures and interactive workshops led by primary care clinical experts. Through this peer-to-peer approach to education, each session will provide you with relevant and practical information that can easily be applied in your practice to improve outcomes in the patients you manage on a daily basis. The Cardiometabolic Risk Summit will feature an array of evidence-based lectures; debates regarding cost-effective diagnostic and treatment strategies; cased-based discussions; interactive workshop sessions; updates on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP4), Eight Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC8) and obesity guidelines; and industry-supported symposia. Hot topics include how to empower patients with diabetes using group visits, getting patients to goal by breaking through clinical inertia, weighing the risks and benefits of statin therapy, creating a patient-centered medical home, safe and effective exercise and nutrition strategies to combat obesity and so much more! We look forward to meeting you in Las Vegas, for what will certainly be a valuable educational experience and enjoyable event! Sincerely,

edward Shahady, Md Course Director, Primary Care Cardiometabolic Risk Summit Editorial Board Member, Consultant President for Medicine NF SG Chapter ADA Medical Director, Diabetes Master Clinician Program FAFP/F Fernandina Beach, Florida

Register early to take advantage of super-saver rates.

Primary Care Cardiometabolic Risk Summit

Accreditation Information
iNteNded leARNeRS This activity is designed for primary care physicians, internists, general practitioners, nurses, nurse practitioners, physician assistants, certified diabetes educators and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic syndrome. leARNiNG oBjeCtiveS After attending the Cardiometabolic Risk Summit, participants should be able to do the following: Develop individualized treatment strategies to delay the progression of hyperglycemia and prediabetes to diabetes, and mitigate cardiometabolic risk for patients already diagnosed with diabetes. Discuss the potential impact of lowering low-density lipoprotein cholesterol, reducing triglycerides and raising high-density lipoprotein cholesterol on cardiometabolic risk. Implement methods for optimizing hypertension treatment and overcoming treatment-resistant disease. Outline how obesity and related comorbidities escalate the risk for cardiometabolic syndrome. ACtivity oveRview The interactive educational conference will occur at Ballys Hotel & Casino in Las Vegas, NV, September 79, 2012. After each educational presentation conducted in a variety of interactive formats the expert faculty will engage in a question-and-answer session with participants. To be eligible for documentation of credit, participants must complete the evaluation form at www. naccme.com. After successfully completing the evaluation, participants can immediately print documentation of credit. HARdwARe/SoFtwARe ReQUiReMeNtS The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com. ACCReditAtioN* In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. CMe NACCME designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CNe This continuing nursing education activity awards 14.5 contact hours. Provider approved by the California Board of Registered Nursing, Provider #13255 for 14.5 contact hours. CMe (ACCePted FoR PHySiCiAN ASSiStANtS) The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit from organizations accredited by the ACCME. AANP This program will be submitted to the American Academy of Nurse Practitioners. *Accreditation information pertains only to the main conference; accreditation information for the satellite symposia will be provided separately. For CE inquiries, please contact NACCME at 609-371-1137, ext. 6207. AdA StAteMeNt North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137. PRivACy PoliCy NACCME protects the privacy of personal and other information regarding participants, educational partners and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individuals consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright 2012 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. 4 Primary Care Cardiometabolic Risk Summit Register online at www.primarycarecardiometabolic.com

FACULTY
CoURSe diReCtoR
edward Shahady, Md Editorial Board Member, Consultant President for Medicine NF SG Chapter ADA Medical Director, Diabetes Master Clinician Program FAFP/F Fernandina Beach, Florida

FACUlty
tara dall, Md, FNlA President/Medical Director, Advanced Lipidology Diplomat, American Board of Clinical Lipidology Delafield, Wisconsin Martha Funnell, MS, RN, Cde Research Investigator Department of Medical Education Diabetes Research and Training Center University of Michigan Medical School Ann Arbor, Michigan louis Kuritzky, Md Assistant Professor Family Medicine Residency Program Gainesville, Florida jeffrey P. levine, Md, MPH Professor/Master Educator Director, Womens Health Programs Department of Family Medicine and Community Health UMDNJ-Robert Wood Johnson Medical School New Brunswick, New Jersey Steven Milligan, Md Diplomat, American Board of Family Practice Fellow, AAPP Southern Colorado Family Medicine Pueblo, Colorado elissa j. Palmer, Md, FAAFP Professor and Chair Department of Family and Community Medicine University of Nevada School of Medicine Las Vegas, Nevada Kevin A. Peterson, Md, MPH Director of Research Department of Family Medicine and Community Health University of Minnesota Medical School Minneapolis, Minnesota darlene Sperlazza, dNP, FNP-BC Instructor in Nursing Wheeling Jesuit University ANCC Certified, Family Nurse Practitioner Weirton, West Virginia

Visit www.PRiMARyCAReCARdioMetAboliC.CoM foR fACulty bios.

NCQAs Facilitating PCMH Recognition Seminar

Call 609-371-1137 for information regarding NCQAs Facilitating PCMH Recognition seminar, scheduled for Sept. 1011, also at Ballys. Information on NCQAs Facilitating PCMH Recognition is available at www.ncqa.org/pcmh.
Register early to take advantage of super-saver rates. Primary Care Cardiometabolic Risk Summit 5

PROGRAM
FRidAy, SePteMBeR 7
4:00 p.m.4:10 p.m.

Friday, September 7 & Saturday, September 8

6:15 p.m.7:15 p.m. Welcome and Pre-Activity Survey Edward Shahady, MD 7:15 p.m.9:15 p.m. Opening Reception in Exhibit Hall Industry-Supported Dinner Symposia

SAtURdAy, SePteMBeR 8
4:10 p.m.4:55 p.m. Cardiometabolic Risk: Definition and Role of Primary Care in Risk Reduction Edward Shahady, MD Cardiometabolic syndrome is a growing epidemic, affecting more than 47 million Americans and more than 45% of U.S. adults older than 60 years of age. The number of patients passing through our practices with this constellation of metabolic abnormalities is significant and increasing each day. As primary care clinicians, we are in an ideal position to effectively access and manage patients with and at risk for cardiometabolic syndrome, but it is essential that we be equipped with a comprehensive understanding of the basic components of cardiometabolic syndrome in order to do our parts in halting this epidemic. 4:55 p.m.5:40 p.m. Cost-Effective Strategies for Accessing and Treating Cardiometabolic Risk Tara Dall, MD, FNLA The estimated annual direct costs of the components of cardiometabolic syndrome are astonishing $90 billion each for obesity and diabetes and $250 billion for cardiovascular disease. As the prevalence increases, the cost of treating cardiometabolic syndrome will be economically devastating for both diagnosed individuals and society as a whole. Additionally, research has shown that lower socioeconomic status if often linked to diabetes and cardiovascular disease, meaning many individuals with cardiometabolic syndrome are already less able to handle significant treatment costs. It is incumbent upon primary care clinicians to utilize the most efficacious, cost-effective strategies to decrease cardiometabolic risk and ensure elimination of cost-associated noncompliance, thereby slowing the skyrocketing cost of care in this therapeutic arena. 5:40 p.m.6:10 p.m. Post-Activity Survey/Q&A Session Edward Shahady, MD, and Tara Dall, MD, FNLA Break 6:30 a.m.8:00 a.m. 8:00 a.m.8:05 a.m. 8:05 a.m.12:10 p.m. Industry-Supported Breakfast Symposia Break Role of Hyperglycemia and diabetes in Cardiometabolic Risk Pre-Activity Survey Kevin A. Peterson, MD, MPH

8:05 a.m.8:10 a.m.

8:10 a.m.8:55 a.m.

Hyperglycemia and Prediabetes: Individualizing Treatment Strategies to Delay Progression to Diabetes Kevin A. Peterson, MD, MPH Although lowering blood glucose levels will not prevent each of the 79 million individuals with prediabetes from developing diabetes, early identification of prediabetes risk, individualized diet and exercise plans, close monitoring and comprehensive patient education strategies discussed in this session can delay a progression to diabetes and even return blood glucose levels to normal. 8:55 a.m.9:40 a.m. Effective Treatment of Type 2 Diabetes Steven Milligan, MD More than 90% of individuals with diabetes are cared for by their primary care provider, emphasizing how important it is for us to understand available therapeutic strategies and feel confident in developing individualized treatment plans for our patients. This session will review effective type 2 diabetes treatments including lifestyle modifications, oral agents and insulinbased regimens and discuss how to determine the best approach for each patient.

6:10 p.m.6:15 p.m.

Primary Care Cardiometabolic Risk Summit

Register online at www.primarycarecardiometabolic.com

Friday, September 7 & Saturday, September 8

PROGRAM

9:40 a.m.10:05 a.m.

Post-Activity Survey/Q&A Session Kevin A. Peterson, MD, MPH, and Steven Milligan, MD Break with Exhibits woRKSHoPS (SELECT 1 oF 4 ToPICS)

10:05 a.m.10:35 a.m. 10:35 a.m.11:20 a.m.

#1 Beta Cell Preservation in diabetes is it Possible? Kevin A. Peterson, MD, MPH Beta cell function in patients with type 2 diabetes declines in a linear manner with time, such that, after 10 years, more than 50% of individuals require insulin therapy. Much attention has been paid in recent years to ways in which we can slow this progression, thereby preserving as many beta cells as possible. This session will provide a review of beta and islet cell biology and evaluate the importance of beta cell regulation in the initiation of diabetes. We will also examine issues influencing beta cell dysfunction, specifically looking at the role of incretins and common incretin abnormalities found in type 2 diabetes. Finally, we will discuss evidence relevant to beta cell preservation and the potential role of beta cell preservation in therapeutic strategies for patients with type 2 diabetes. #2 evidence Supporting Clinical Practice Activities: Antiplatelet therapy, eye Care, Foot Care and Supplements Elissa J. Palmer, MD, FAAFP Complete management of our patients with cardiometabolic risk includes preventing and, if necessary, treating the myriad comorbidities and complications associated with the components of cardiometabolic syndrome. The arsenal to combat the potentially devastating consequences of diabetes, obesity and cardiovascular disease includes aspirin, prescription agents and over-the-counter supplements. We will focus on the evidence-based recommendations to effectively implement these tools into your practice, ensuring the smoothest-possible treatment path for your patients. #3 Creating a Medical Home with diabetes Registries, empowered office Staff and Group visits Edward Shahady, MD The patient-centered medical home is an effective model to meet the majority of patients healthcare needs in a comprehensive and coordinated team-based approach to care. During this session, Dr. Shahady will provide an overview of the criteria and principles for establishing a medical home. Successful creation of a patient-centered medical home, use of a diabetes registry, empowerment of office staff and implementation of group visits within a primary care practice will be examined through case examples of practices that used these strategies to increase goal achievement while reducing costs and patient complications.

Register early to take advantage of super-saver rates.

Primary Care Cardiometabolic Risk Summit

PROGRAM

Saturday, September 8
#4 Patient empowerment: From Compliance to Collaboration Martha Funnell, MS, RN, CDE Providing patient-centered care to prevent and treat chronic illness is a constant challenge within our ever-evolving healthcare system, and its a challenge clinicians cannot face alone. Patient empowerment is a powerful tool to successful management of chronic illness, providing an effective framework for the development and implementation of patient-centered intervention strategies that enable patients to assume responsibility for daily diabetes care. During this session, practical examples of efficient and effective communication skills will be paramount for ensuring that providers interact in the best possible manner with patients, and that patients recognize the enormous effect their involvement and cooperation can have on their health. 11:20 a.m.11:25 a.m. Break 1:20 p.m.1:25 p.m. Pre-Activity Survey Edward Shahady, MD

1:25 p.m.2:10 p.m.

Lowering LDL: How To Do It and Is It of Value? Edward Shahady, MD Benefits associated with lowering low-density lipoprotein (LDL) cholesterol have been the focus of controversy in recent years, perhaps contributing to ambivalence regarding the necessity of addressing increased LDL with the clinical fervor seen in the past. This issue remains a vital component of cardiometabolic risk, however, and this session will begin by reviewing evidence indicating lowering LDL reduces cardiovascular mortality and morbidity. The question of the most effective means of reducing LDL remains an important one, and Dr. Shahady will engage the audience in a discussion of lifestyle changes and available statin agents, focusing on the benefits, therapeutic limitations and safety in lowering LDL cholesterol, and the utility of these agents in improving other cardiovascular risk factors. 2:10 p.m.2:55 p.m. Lowering Triglycerides and Raising HDL: How To Do It and Is It of Value? Tara Dall, MD, FNLA Although decreasing low-density lipoprotein (LDL) cholesterol is vital to the treatment of dislipidemia, the optimal LDL-lowering regimen may only reduce ischemic vascular disease by 50%, leaving significant room for additionally reducing cardiovascular risk. Elevating highdensity lipoprotein (HDL) cholesterol and lowering trigylcerides may be the key to striking a better blood-cholesterol balance. The potential impact of targeting HDL and triglycerides for better cardiovascular protection will be addressed in this session. Nonpharmaceutical strategies to increase HDL and reduce triglycerides will be discussed, as will the benefits and limitations of viable pharmaceutical options for treatment. 2:55 p.m.3:20 p.m. Post-Activity Survey/Q&A Session Edward Shahady, MD, and Tara Dall, MD, FNLA Break with Exhibits

11:25 a.m.12:20 p.m.

woRKSHoPS (SELECT 1 oF 4 ToPICS) (See abstracts #1#4 for details.)

#5 Beta Cell Preservation in diabetes is it Possible? #6 evidence Supporting Clinical Practice Activities: Antiplatelet therapy, eye Care, Foot Care and Supplements #7 Creating a Medical Home with diabetes Registries, empowered office Staff and Group visits #8 Patient empowerment: From Compliance to Collaboration 12:20 p.m.1:20 p.m. 1:20 p.m.5:25 p.m. Lunch with Exhibits Role of lipids in Cardiometabolic Risk

3:20 p.m.3:50 p.m.

Primary Care Cardiometabolic Risk Summit

Register online at www.primarycarecardiometabolic.com

Saturday, September 8 & Sunday, September 9

PROGRAM

3:50 p.m. 4:35 p.m.

woRKSHoPS (SELECT 1 oF 4 ToPICS)

#9 Statins weighing the Risks and Benefits of therapy Louis Kuritzky, MD Although cardiovascular-risk reduction with statin therapy is well-established, clinicians may find themselves less well informed about potential risks of treatment. Fortunately, severe myopathy is rare, but dealing with myalgias, elevations of creatine phosphokinase and abnormal liver-function tests are each common challenges that can be addressed in the primary care setting. This presentation will highlight tools for negotiating the most frequent statin toxicities seen in clinical practice. #10 effective Patient education Activities and Materials for Cardiometabolic Risk Martha Funnell, MS, RN, CDE As providers, it is essential to recognize that telling patients what they should do and why they should do it does not adequately effect long-lasting behavior change. Effective self-management education also involves teaching patients how to make the changes necessary to lower their risks and improve outcomes. This session will discuss patient-centered educational methods and other reliable resources, and provide practical ways of incorporating behavior-change strategies into clinical practice. #11 diminishing the Burden of dyslipidemia in CKd Edward Shahady, MD A staggering number of patients with chronic kidney disease (CKD) are affected by dyslipidemia, placing these individuals at risk for acute and chronic cardiovascular (CV) disease, recurrent heart attack, stroke and congestive heart failure. Poor control of dyslipidemia and other common comorbid conditions such as diabetes and hypertension can accelerate CKD progression and ultimately result in end-stage renal disease. This session will discuss strategies for reducing low-density lipoprotein cholesterol in an effort to slow the progression of CKD, limit CV mortality and mitigate overall cardiometabolic risk.

#12 lipids in Children: Challenges and Solutions Tara Dall, MD, FNLA A variety of factors can contribute to the development of dyslipidemia in children, including obesity and family history. Regardless of the cause, appropriate management of cholesterol levels is warranted to delay progression to cardiovascular complications, including heart disease. This session will demonstrate how to implement strategies for applying available lipid guidelines for the management of familial hypercholesterolemia, describe the appropriate workup for dyslipidemia and insulin resistance and discuss evaluating weight/obesity in young children. 4:35 p.m. 4:40 p.m. 4:40 p.m. 5:25 p.m. Break woRKSHoPS (SELECT 1 oF 4 ToPICS) (See abstracts #9#12 for details.)

#13 Statins weighing the Risks and Benefits of therapy #14 effective Patient education Activities and Materials for Cardiometabolic Risk #15 diminishing the Burden of dyslipidemia in CKd #16 lipids in Children: Challenges and Solutions 5:25 p.m.8:00 p.m. Industry-Supported Reception and Dinner Symposia

SUNdAy, SePteMBeR 9
6:30 a.m.8:00 a.m. 8:00 a.m.8:05 a.m. 8:05 a.m.12:10 p.m. Industry-Supported Breakfast Symposia Break Role of Hypertension in Cardiometabolic Risk

Register early to take advantage of super-saver rates.

Primary Care Cardiometabolic Risk Summit

PROGRAM
8:05 a.m.8:10 a.m.

Sunday, September 9

Pre-Activity Survey Steven Milligan, MD

patient nonadherence, volume overload and psudotolerance, and drug-induced resistant hypertension and offer strategies for overcoming these obstacles. #18 Health disparities and Special Populations in Cardiometabolic Risk Elissa J. Palmer, MD, FAAFP Understanding disparities based on gender, ethnicity and age is essential to developing effective patient-centered regimens for mitigating cardiometabolic risk. This session will review available evidence and identify current methods as applicable to different populations at risk for cardiometabolic syndrome. #19 Understanding the Basics: Safe, effective exercise to Combat Cardiometabolic Risk Darlene Sperlazza, DNP, FNP-BC Among the most basic yet effective strategies for combating cardiometabolic risk, physical activity provides a safe and effective method for impacting patient outcomes. This session will discuss ways to motivate patients to change their lifestyles in an effort to delay disease progression and offer practical tactics for implementing programs that assist patients in reaching exercise-related goals. #20 the Role of Nutrition in Reducing Cardiometabolic Risk Martha Funnell, MS, RN, CDE The importance of nutrition for reducing cardiometabolic risk is well-documented, but it is often the most challenging aspect of care for patients and healthcare providers. By identifying the impact of macronutrients and the role of medical nutrition therapy on cardiometabolic risk factors, this session will demonstrate just how pivotal nutrition is in maintaining overall health and will provide practical strategies for incorporating nutrition management into regular office visits. 11:20 a.m.11:25 a.m. Break woRKSHoPS (SELECT 1 oF 4 ToPICS) (See abstracts #17#20 for details.)

8:10 a.m.8:55 a.m.

The Epidemiology of Hypertension and Cardiometabolic Risk and Their Impact on Patient Outcomes Steven Milligan, MD Affecting approximately one-third of adults in the United States, hypertension is an important target when combating cardiometabolic risk. This lecture will investigate the prevalence of hypertension in different and diverse populations and discuss how these factors affect treatment. The session will also explore the relationship between hypertension and other aspects of cardiometabolic risk, including obesity and dyslipidemia, and discuss how healthcare providers can improve patient outcomes through effective antihypertensive therapies. 8:55 a.m.9:40 a.m. Optimizing Hypertension Treatment: Choices and Goals for Patients with Cardiometabolic Risk Louis Kuritzky, MD Healthcare providers have several options with regard to hypertension management, yet the difficulty remains: How do we individualize therapy to optimize patient outcomes? This session will offer practical strategies for translating National Institute for Health and Clinical Excellence guidelines for hypertension into clinical practice and creating hypertension treatment plans for your patients to manage cardiometabolic risk. 9:40 a.m.10:05 a.m. Post-Activity Survey/Q&A Session Steven Milligan, MD, and Louis Kuritzky, MD Break with Exhibits woRKSHoPS (SELECT 1 oF 4 ToPICS)

10:05 a.m.10:35 a.m. 10:35 a.m.11:20 a.m.

#17 overcoming Resistant Hypertension: Strategies for Getting Patients to Goal Steven Milligan, MD Whether due to patient nonadherence or comorbid conditions, healthcare providers are often faced with the challenge of determining why their patients are not reaching their hypertensive goals. This session will explore the possible reasons for resistant hypertension including

11:25 a.m.12:10 p.m.

#21 overcoming Resistant Hypertension: Strategies for Getting Patients to Goal

10

Primary Care Cardiometabolic Risk Summit

Register online at www.primarycarecardiometabolic.com

PROGRAM
#22 Health disparities and Special Populations in Cardiometabolic Risk #23 Understanding the Basics: Safe, effective exercise to Combat Cardiometabolic Risk #24 the Role of Nutrition in Reducing Cardiometabolic Risk 12:10 p.m.1:20 p.m. 1:20 p.m.3:20 p.m. 1:20 p.m.1:25 p.m. Lunch with Exhibits Role of obesity in Cardiometabolic Risk Pre-Activity Survey Tara Dall, MD, FNLA

1:25 p.m.2:10 p.m.

Focus on Management of Obesity and Comorbidities: Determining the Right Approach for Obese Patients Tara Dall, MD, FNLA over the past 20 years, the Centers for Disease Control and Prevention has noted a dramatic increase in obesity in the United States, with current estimates suggesting that approximately one-third of the adult population is obese. If fact, in 2010, none of the 50 states reported an obesity prevalence rate lower than 20% an statistic that is truly cause for alarm. This session will review the current rates of adult and child obesity in the United States and discuss the relationship between obesity and other conditions, including cancer, diabetes, cardiovascular disease and premature mortality. It will also offer strategies for identifying and treating secondary causes of obesity such as various medical factors, medications and insulin resistance. 2:10 p.m.2:55 p.m. Confessions of a Biggest Loser: Promoting Healthy Lifestyles to Our Patients by Practicing What We Teach Jeffrey P. Levine, MD, MPH Anyone who has every struggled with obesity can tell you that losing weight is more than just counting calories. It is a matter of adopting an active lifestyle and healthier eating habits a task that is easier said than done. Pulling from personal experience as an obesity survivor and evidence-based weight management strategies, Dr. Levine will discuss his experience as a contestant on the hit television show, The Biggest Loser, and ways to promote healthy lifestyles to our patients and communities. 2:55 p.m.3:20 p.m. Post-Activity Survey/Q&A Session Tara Dall, MD, FNLA, and Jeffrey P. Levine, MD, MPH

tHe CARdioMetABoliC RiSK SUMMit exHiBit HAll CoveRS it All

The 2012 Cardiometabolic Risk Summit will feature a comprehensive exhibit hall showcasing the latest products and modalities available in cardiometabolic risk assessment and treatment. Research and advances in clinical practice are increasingly changing the way patients are treated and, as healthcare providers, you are under increasing pressure to improve patient outcomes. There is no other primary care meeting or educational conference that provides greater access to more exhibitors within the arena of reducing cardiometabolic risk than this meeting. If you are interested in exhibiting, please contact Ryan Bowes at 609-630-6217.
11

Register early to take advantage of super-saver rates.

Primary Care Cardiometabolic Risk Summit

SCHEDULE AT A GLANCE
FRidAy, SePteMBeR 7 4:00 p.m.4:10 p.m. 4:10 p.m.4:55 p.m 4:55 p.m.5:40 p.m. 5:40 p.m.6:10 p.m. 6:10 p.m.6:15 p.m. 6:15 p.m.7:15 p.m. 7:15 p.m.9:15 p.m. SAtURdAy, SePteMBeR 8 6:30 a.m.8:00 a.m. 8:00 a.m.8:05 a.m. Industry-Supported Breakfast Symposia Break Welcome and Pre-Activity Survey Cardiometabolic Risk: Definition and Role of Primary Care in Risk Reduction Cost-Effective Strategies for Accessing and Treating Cardiometabolic Risk Post-Activity Survey/Q&A Session Break Opening Reception in Exhibit Hall Industry-Supported Dinner Symposia Edward Shahady, MD Edward Shahady, MD Tara Dall, MD, FNLA Edward Shahady, MD, and Tara Dall, MD, FNLA

Role oF HyPeRGlyCeMiA ANd diABeteS iN CARdioMetABoliC RiSK 8:05 a.m.8:10 a.m. 8:10 a.m.8:55 a.m. 8:55 a.m. 9:40 a.m 9:40 a.m.10:05 a.m 10:05 a.m.10:35 a.m. 10:35 a.m.11: 20 a.m. Pre-Activity Survey Hyperglycemia and Prediabetes: Individualizing Treatment Strategies to Delay Progression to Diabetes Effective Treatment of Type 2 Diabetes Post-Activity Survey/Q&A Session Break with Exhibits woRKSHoPS: Role of Hyperglycemia and diabetes in Cardiometabolic Risk (Select 1 of 4 topics.) #2 Evidence Supporting Clinical Practice Activities: Antiplatelet Therapy Eye Care, Foot Care and Supplements Elissa J. Palmer, MD, FAAFP #4 Patient Empowerment: From Compliance to Collaboration Martha Funnell, MS, RN, CDE Kevin A. Peterson, MD, MPH Kevin A. Peterson, MD, MPH Steven Milligan, MD Kevin A. Peterson, MD, MPH, and Steven Milligan, MD

#1 Beta Cell Preservation in Diabetes Is It Possible? Kevin A. Peterson, MD, MPH #3 Creating a Medical Home with Diabetes Registries, Empowered Office Staff and Group Visits Edward Shahady, MD 11:20 a.m.11:25 a.m. 11:25 a.m.12:20 p.m. Break

woRKSHoPS: Role of Hyperglycemia and diabetes in Cardiometabolic Risk (Select 1 of 4 topics.) #6 Evidence Supporting Clinical Practice Activities: Antiplatelet Therapy Eye Care, Foot Care and Supplements Elissa J. Palmer, MD, FAAFP #8 Patient Empowerment: From Compliance to Collaboration Martha Funnell, MS, RN, CDE

#5 Beta Cell Preservation in Diabetes Is It Possible? Kevin A. Peterson, MD, MPH #7 Creating a Medical Home with Diabetes Registries, Empowered Office Staff and Group Visits Edward Shahady, MD 12:20 p.m.1:20 p.m. Lunch with Exhibits

Role oF liPidS iN CARdioMetABoliC RiSK 1:20 p.m. 1:25 p.m. 1:25 p.m.2:10 p.m. 2:10 p.m.-2:55 p.m. 2:55 p.m. 3:20 p.m. 3:20 p.m.3:50 p.m. Pre-Activity Survey Lowering LDL: How To Do It and Is It of Value? Lowering Triglycerides and Raising HDL: How To Do It and Is It of Value? Post-Activity Survey/Q&A Session Break with Exhibits Edward Shahady, MD Edward Shahady, MD Tara Dall, MD, FNLA Edward Shahady, MD, and Tara Dall, MD, FNLA

12

Primary Care Cardiometabolic Risk Summit

Register online at www.primarycarecardiometabolic.com

SCHEDULE AT A GLANCE
SAtURdAy, SePteMBeR 8 3:50 p.m.4:35 p.m. woRKSHoPS: Role of lipids in Cardiometabolic Risk (Select 1 of 4 topics.) #10 Effective Patient Education Activities and Materials for Cardiometabolic Risk Martha Funnell, MS, RN, CDE #12 Lipids in Children: Challenges and Solutions Tara Dall, MD, FNLA #9 Statins Weighing the Risks and Benefits of Therapy Louis Kuritzky, MD #11 Diminishing the Burden of Dyslipidemia in CKD Edward Shahady, MD 4:35 p.m.4:40 p.m. 4:40 p.m.5:25 p.m. Break woRKSHoPS: Role of lipids in Cardiometabolic Risk (Select 1 of 4 topics.) #14 Effective Patient Education Activities and Materials for Cardiometabolic Risk Martha Funnell, MS, RN, CDE #16 Lipids in Children: Challenges and Solutions Tara Dall, MD, FNLA

#13 Statins Weighing the Risks and Benefits of Therapy Louis Kuritzky, MD #15 Diminishing the Burden of Dyslipidemia in CKD Edward Shahady, MD 5:25 p.m.6:00 p.m. 6:00 p.m. 8:00 p.m. SUNdAy, SePteMBeR 9 6:30 a.m.8:00 a.m. 8:00 a.m.8:05 a.m Industry-Supported Breakfast Symposia Break Industry-Supported Reception Industry-Supported Dinner Symposia

Role oF HyPeRteNSioN iN CARdioMetABoliC RiSK 8:05 a.m.8:10 a.m. 8:10 a.m.8:55 a.m. 8:55 a.m.9:40 a.m. 9:40 a.m.10:05 a.m. 10:05 a.m.10:35 a.m. 10:35 a.m.11:20 a.m. Pre-Activity Survey The Epidemiology of Hypertension and Cardiometabolic Risk and Their Impact on Patient Outcomes Optimizing Hypertension Treatment: Choices and Goals for Patients with Cardiometabolic Risk Post-Activity Survey/Q&A Session Break with Exhibits woRKSHoPS: Role of Hypertension in Cardiometabolic Risk (Select 1 of 4 topics.) #18 Health Disparities and Special Populations in Cardiometabolic Risk Elissa J. Palmer, MD, FAAFP #20 The Role of Nutrition in Reducing Cardiometabolic Risk Martha Funnell, MS RN, CDE Steven Milligan, MD Steven Milligan, MD Louis Kuritzky, MD Steven Milligan, MD, and Louis Kuritzky, MD

#17 Overcoming Resistant Hypertension: Strategies for Getting Patients to Goal Steven Milligan, MD #19 Understanding the Basics: Safe, Effective Exercise to Combat Cardiometabolic Risk Darlene Sperlazza, DNP, FNP-BC 11:20 a.m.11:25 a.m. 11:25 a.m.12:10 p.m. Break woRKSHoPS: Role of Hypertension in Cardiometabolic Risk (Select 1 of 4 topics.)

#21 Overcoming Resistant Hypertension: Strategies for Getting Patients to Goal Steven Milligan, MD #23 Understanding the Basics: Safe, Effective Exercise to Combat Cardiometabolic Risk Darlene Sperlazza, DNP, FNP-BC 12:10 p.m.1:20 p..m. Lunch with Exhibits

#22 Health Disparities and Special Populations in Cardiometabolic Risk Elissa J. Palmer, MD, FAAFP #24 The Role of Nutrition in Reducing Cardiometabolic Risk Martha Funnell, MS RN, CDE

Role oF oBeSity iN CARdioMetABoliC RiSK 1:20 p.m.1:25 p.m. 1:25 p.m.2:10 p.m. 2:10 p.m.2:55 p.m. 2:55 p.m.3:20 p.m. 3:20 p.m. Pre-Activity Survey Focus on Management of Obesity and Comorbidities: Determining the Right Approach for Obese Patients Confessions of a Biggest Loser: Promotoing Healthy Lifestyles to Our Patients by Practicing What We Teach Post-Activity Survey/Q&A Session Conference Adjourns Tara Dall, MD, FNLA Tara Dall, MD, FNLA Jeffrey P. Levine, MD, MPH Tara Dall, MD, FNLA, and Jeffrey P. Levine, MD, MPH

Register early to take advantage of super-saver rates.

Primary Care Cardiometabolic Risk Summit

13

HOTEL & TRAVEL INFORMATION

Ballys Hotel & Casino 3645 Las Vegas Boulevard South Las Vegas, Nevada 877-603-4390 www.ballyslasvegas.com The Cardiometabolic Risk Summit will be held at the Ballys Hotel & Casino in Las Vegas. This hotel is located on the famous Las Vegas Strip. Known for its elegant style, timeless glamour and high-rolling excitement, Ballys has been the soul in the city that refuses to sleep. Stay at Ballys and experience the hotels unwavering service, professionalism and signature style that have been celebrated for over 30 years. Hotel ReSeRvAtioN iNFoRMAtioN Reservations are now being accepted for the Cardiometabolic Risk Summit. A limited block of rooms is being held at Ballys for conference attendees at a discounted rate of $109 per night for single or double occupancy. There is also a small block of rooms being held at Paris Las Vegas (adjacent to Ballys) for $139 per night for single or double occupancy. To receive the special reduced rate, you must reserve before Monday, August 13, 2012 and reference the group name Cardiometabolic Risk Summit. The room rates will be available 3 days pre- and post-conference, based on availability. We encourage you to book your rooms early, as these hotels sell out quickly. To reserve a room at Ballys Hotel & Casino, please call 800-358-9777; to reserve a room at the Paris Las Vegas Hotel, please call 877-603-4389; or book at www.primarycarecardiometabolic.com/hotel Please note that one nights deposit is required to hold your reservation and is non-refundable in the event of cancellation. CHeCK-iN ANd CHeCK-oUt Check in time is 4:00 p.m. and check out time is 11:00 a.m. AiRliNe ReSeRvAtioNS To make airline reservations, please call HMP Travel at 800-237-7285, ext. 218. Please note there is a $35 charge per ticket for this service. Ballys is located just minutes from McCarran International Airport. Cab transportation to the hotel costs approximately $20, depending on traffic.

14

Primary Care Cardiometabolic Risk Summit

Register online at www.primarycarecardiometabolic.com

For registration or general information questions, please call 800-237-7285 x233

REGISTRATION FORM
woRKSHoP ReGiStRAtioN All general sessions will be included in your registration. Please check one workshop per time period below. Saturday, September 8 See pages 79 for workshop titles and descriptions. 10:35 a.m.11:20 a.m. q #1 q #2 q #3 11:25 a.m.12:20 p.m. q #5 q #6 3:50 p.m.4:35 p.m. q #9 q #10 4:40 p.m.5:25 p.m. q #13 q #14

___________________________________________________________ First name ___________________________________________________________ Last name ___________________________________________________________ Suffix/credentials ___________________________________________________________ Title ___________________________________________________________ Company/organization name ___________________________________________________________ Address 1 ___________________________________________________________ Address 2 ___________________________________________________________ City State Zip Country ___________________________________________________________ Telephone Fax ___________________________________________________________ E-mail address (Confirmations will be sent via e-mail.)

PRoFeSSioNAl CAteGoRy q MD q DO q NP SPeCiAlty AReA q Internal medicine q Geriatrics q Other q Primary care/ family medicine q MSN/BN/RN/PA/CDE q Other allied q Industry

q #4

q #7

q #8

in which care setting is the MAjoRity of your time spent? q Office-based q Hospital q Other

q #11

q #12

what percentage of your patients are at risk for cardiometabolic syndrome? q Less than 25% q 35% q 50% q 65% q More than 75%

q #15

q #16

Sunday, September 9 See pages 1011 for workshop titles and descriptions. 10:35 a.m.11:20 p.m. q #17 q #18 q #19 11:25 a.m.12:10 p.m. q #21 q #22 q #23

q #20 q #24

How many years have you been in practice? ______

CoNFeReNCe ReGiStRAtioN
Super-saver
(Before May 6)

early-bird
(Before july 15)

Regular
(After july 16)

MD/DO MSN/BN/RN/ NP/PA/CDE Other allied Industry

$195 $125 $125 $495

$295 $195 $195 $495

$495 $295 $295 $495 $195

Student

$25

$95

CoUPoN Code

_________________

totAl PAyMeNt eNCloSed

$ ______________

CANCellAtioN PoliCy q Credit card (check one): Please note the cut-off date for cancellation is July 16, q Visa q Mastercard 2012. All cancellations must be received in writing and q American Express q Discover postmarked by that date. Full registration (less a $75 processing fee) will be refunded only to cancellations received in writing before the above date. No refunds ___________________________________________________________ will be issued after July 16, 2012 without exception. Name on card (please print) Registrations are transferable at any time. ___________________________________________________________ Credit card number MetHod oF PAyMeNt Choose from the following options: ___________________________________________________________ Expiration date q Check Make check payable to HMP Communications. All checks must be drawn on a U.S. bank in U.S. funds. ___________________________________________________________ Security code Billing postal code Mail to ___________________________________________________________ 83 General Warren Blvd., Suite 100 Signature (required) Malvern, PA 19355

Register early to take advantage of super-saver rates.

Primary Care Cardiometabolic Risk Summit

15

September 79, 2012

Hypertension DyslipiDemia Diabetes obesity

Attendee Brochure
Partnering organizations:

Register online at www.primarycarecardiometabolic.com

Register online at www.primarycarecardiometabolic.com

Ballys Hotel & Casino Las Vegas, Nevada

September 79, 2012

83 General Warren Blvd Suite 100 Malvern, PA 19355

Ballys Hotel & Casino Las Vegas, Nevada

, LLC